Photobiomodulation to minimize talquetamab-associated dysgeusia and xerostomia in multiple myeloma: a brief report of four cases.
Four patients receiving talquetamab for multiple myeloma experienced taste changes and dry mouth; photobiomodulation therapy was tolerated without adverse events, though the small uncontrolled study cannot determine whether it helped reduce these side effects.
A plain-English summary of the study's own findings — we don't add our own claims or interpretation. Read the full paper for the complete methods and results, and apply your own clinical judgement.
Read the full study at the sourceRelated CPD from Vital Pulp
Managing the Pregnant Dental Patient
Confident, evidence-based dental care from the first trimester to the postpartum period
The Recall — the month's most significant new dental research, summarised. Free.
Browse The Recall